Beneficial effects of dilazep on the palmitoyl-L-carnitine-induced derangements in isolated, perfused rat heart: Comparison with tetrodotoxin

Japanese Journal of Pharmacology

Volumn 74, Issue 2, 1997, Pages 147-153

  Hara, Akiyoshi ^a   Arakawa, Johji ^a   Hashizume, Hiroko ^a   Abiko, Yasushi ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

Dilazep; Heart (rat); Long chain acylcarnitine; Na+ channel; Tetrodotoxin

Indexed keywords

ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; DILAZEP; PALMITOYLCARNITINE; SODIUM CHANNEL; TETRODOTOXIN;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HEART INJURY; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE METABOLISM; ISOLATED HEART; MALE; NONHUMAN; RAT;

EID: 0030758024     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.74.147     Document Type: Article

References (28)

1. Corr PB, Saffitz JE and Sobel BE: Lysophospholipids, long chain acylcarnitines and membrane dysfunction in the ischaemic heart. Basic Res Cardiol 82, Supp 1, 199-208 (1987)
2. DaTorre SD, Creer MH, Pogwizd SM and Corr PB: Amphipathic lipid metabolites and their relation to arrhythmogenesis in the ischemic heart. J Mol Cell Cardiol 23, Supp I, 11-22 (1991)
3. Corr PB, Creer MH, Yamada KA, Saffitz JE and Sobel BE: Prophylaxis of early ventricular fibrillation by inhibition of acylcarnitine accumulation. J Clin Invest 83, 927-936 (1989)
4. Yamada KA, McHowat J, Yan G-X, Donahue K, Peirick J, Kléber AG and Corr PB: Cellular uncoupling induced by accumulation of long-chain acylcarnitine during ischemia. Circ Res 74, 83-95 (1994)
5. Hara A, Akahira M and Abiko Y: Effect of K-7259, a novel derivative of dilazep, on cardiovascular actions of adenosine: Comparison with dilazep. Arch Int Pharmacodyn Ther 330, 66-75 (1995)
6. Wu J and Corr PB: Palmitoyl carnitine modifies sodium currents and induces transient inward current in ventricular myocytes. Am J Physiol 266, H1034-H1046 (1994)
7. i and initiates transient inward current in adult ventricular myocytes. Am J Physiol 268, H2405-H2417 (1995)
8. Busselen P, Sercu D and Verdonck F: Exogenous palmitoyl carnitine and membrane damage in rat hearts. J Mol Cell Cardiol 20, 905-916 (1988)
9. Shikama H, Noshiro O, Ohta A and Ohata I: Effects of acylcarnitine-transferase inhibitors on adenine nucleotide metabolism and ischemic tissue injury in isolated perfused rat heart. Jpn Heart J 29, 723-734 (1988)
10. Hara A, Hashizume H and Abiko Y: Dilazep and its derivative, K-7259, attenuate mechanical derangement induced by palmitoyl-L-carnitine in the isolated, perfused rat heart. J Pharmacol Exp Ther 279, 32-38 (1996)
11. Mustafa SJ: Effects of coronary vasodilator drugs on the uptake and release of adenosine in cardiac cells. Biochem Pharmacol 28, 2617-2624 (1979)
12. Van Belle H: Nucleoside transport inhibition: a therapeutic approach to cardioprotection via adenosine ? Cardiovasc Res 27, 68-76 (1993)
13. Chiba K, Hashizume H, Inagaki S-I and Abiko Y: Dilazep inhibits binding of batrachotoxin to sodium channels in canine sarcolemmal vesicles. Arch Int Pharmacodyn Ther 330, 138-150 (1995)
14. Hashizume H, Akiyama K and Abiko Y: Effects of antiischemic drugs on veratridine-induced hypercontracture in rat cardiac myocytes. Eur J Pharmacol 271, 1-8 (1994)
15. Xiao C-Y, Chen M, Kara A, Hashizume H and Abiko Y: Effects of palmitoyl-L-carnitine on energy and lipid metabolism in the heart (Abstract). J Mol Cell Cardiol 28, A336 (1996)
16. Bergmeyer HU: Methods of Enzymatic Analysis. pp 1777-1781, 2101-2110, 2127-2131, Academic Press, New York (1974)
17. Nakagawa Y, Gudenzi M and Mustafa SJ: Calcium entry blocking activity of dilazep in dog coronary artery. Pharmacology 33, 148-156 (1986)
18. Nakagawa Y, Gudenzi M and Mustafa SJ: Calcium entry blocking activity of dilazep and other adenosine potentiating compounds in guinea pig atria. Eur J Pharmacol 122, 51-58 (1986)
19. Hara A and Abiko Y: Protective effects of dilazep and its derivative, K-7259, on mechanical and metabolic derangements induced by hydrogen peroxide in the isolated perfused rat heart. J Pharmacol Exp Ther 277, 565-571 (1996)
20. Nayler WG, Panagiotopoulos S, Elz JS and Daly MJ: Calcium-mediated damage post-ischaemic reperfusion. J Mol Cell Cardiol 20, Supp II, 41-54 (1988)
21. Clarke B, Wyatt KM, May GR and McCormack JG: On the roles of long-chain acyl carnitine accumulation and impaired glucose utilization in ischaemic contracture development and tissue damage in the guinea pig heart. J Mol Cell Cardiol 28, 171-181 (1996)
22. Catterall WA and Coppersmith J: Pharmacological properties of sodium channels in cultured rat heart cells. Mol Pharmacol 20, 533-542 (1981)
23. + channel subtypes in nerve, heart, and skeletal muscle. Ann NY Acad Sci 479, 402-430 (1987)
24. Undrovinas AI, Fleidervish IA and Makielski JC: Inward sodium current at resting potentials in single cardiac myocytes induced by the ischemic metabolite lysophosphatidylcholine. Circ Res 71, 1231-1241 (1992)
25. Hoque ANE, Hoque N, Hashizume H and Abiko Y: A study on dilazep: II. Dilazep attenuates lysophosphatidylcholine-induced mechanical and metabolic derangements in the isolated, working rat heart. Jpn J Pharmacol 67, 233-241 (1995)
26. Kang JX and Leaf A: Protective effects of free polyunsaturated fatty acids on arrhythmias induced by lysophosphatidylcholine or palmitoylcarinitine in neonatal rat cardiac myocytes. Eur J Pharmacol 297, 97-106 (1996)
27. Hoque ANE, Hoque N, Hashizume H and Abiko Y: A study on dilazep: I. Mechanism of anti-ischemic action of dilazep is not coronary vasodilation but decreased cardiac mechanical function in the isolated, working rat heart. Jpn J Pharmacol 67, 225-232 (1995)
28. Meghji P, Middleton K, Hassall CJS, Phillips MI and Newby AC: Evidence for extracellular deamination of adenosine in the rat heart. Int J Biochem 20, 1335 -1341 (1988)